SSTR1

Somatostatin receptor 1 (SSTR1) is a seven-transmembrane G protein-coupled receptor that mediates the biological effects of somatostatin and exhibits higher affinity for somatostatin-14 than somatostatin-28^[1][2]. SSTR1 primarily couples to pertussis toxin-sensitive G proteins and contributes to inhibition of adenylyl cyclase signaling, thereby regulating secretory and cellular responses in multiple tissues^[1][3]. As a member of the somatostatin receptor family, SSTR1 participates in the broader inhibitory network through which somatostatin controls hormone secretion, cell proliferation, and tissue homeostasis^[3][4]. Mechanistically, activation of SSTR1 is associated with anti-secretory, anti-proliferative, and anti-migratory effects, supporting its role in cellular growth control and signaling regulation^[4]. In disease-related settings, somatostatin receptors are expressed in numerous neuroendocrine and other tumor types, and emerging clinical evidence indicates that reduced SSTR1 expression is associated with androgen receptor signaling inhibitor resistance and poorer overall survival in metastatic castration-resistant prostate cancer^[4]. Compared with related receptor isoforms, SSTR1 belongs to a distinct somatostatin receptor subclass that differs from SSTR2, SSTR3, and SSTR5 in ligand recognition and reactivity toward somatostatin analogs, highlighting subtype-specific pharmacology and signaling properties^[3]. Structural studies further demonstrate isoform-dependent differences in ligand-binding interactions across the five somatostatin receptors, providing a framework for the development of subtype-selective compounds. For experimental applications, selective SSTR1 agonists and antagonists have been developed and are used to investigate receptor-specific signaling, secretion control, and antiproliferative responses in cellular and disease models^[5].